| (210) | Number of the EPO application | 19801033 |
| (220) | Filing date of the EPO application | 2019.11.13 |
| (80) | EPO patent specification publication (B) | EPB nr. 39/2022, 2022.09.28 |
| (110) | EPO patent number | 3880818 |
| (11) | Number of the document | MD 3880818 T2 |
| (21) | Number of the application | e 2021 0897 |
| (71) | Name(s) of applicant(s), code of the country | Silence Therapeutics GmbH, DE; |
| (72) | Name(s) of inventor(s), code of the country | RIDER David Anthony, DE;
BETHGE Lucas, DE;
FRAUENDORF Christian, DE;
WEINGAERTNER Adrien, DE;
HAUPTMANN Judith, DE;
DAMES Sibylle, DE;
SCHUBERT Steffen, DE;
TENBAUM Stephan, DE; |
| (73) | Name(s) of owner(s), code of the country | Silence Therapeutics GmbH, DE; |
| (54) | Title of the invention | Nucleic acids for inhibiting expression of LPA in a cell |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C12N 15/113 (2010.01.01); A61K 31/713 (2006.01.01); A61P 9/00 (2006.01.01) |
| (19) | Country | DE |
| (41) | Date of publication of the application | 2021.10.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2023.01.31 |
| (30) | Priority | PCT/EP2018/0811, 2018.11.13, WO; 19174466, 2019.05.14, EP |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
| (86) | International application | PCT/EP2019/081158, 2019.11.13 |
| (87) | International publication | WO 2020/099476, 2020.05.22 |